Literature DB >> 24035596

The complement anaphylatoxin receptors are not required for the development of experimental autoimmune uveitis.

Russell W Read1, Susan D Vogt, Scott R Barnum.   

Abstract

To determine if complement anaphylatoxin-mediated inflammation contributes to the development and progression of experimental autoimmune uveitis (EAU), we induced disease in wild type and complement anaphylatoxin receptor-deficient mice (C3a receptor(-/-), C5a receptor(-/-) and C3aR(-/-)/C5aR(-/-)) and evaluated the eyes three weeks post-induction. No differences in disease severity or in disease incidence were seen between wild type controls and anaphylatoxin receptor-deficient mice. Our data indicate that C3a and C5a-mediated functions are not critical to the development of EAU.
© 2013.

Entities:  

Keywords:  Anaphylatoxins; Complement; Experimental autoimmune uveoretinitis

Mesh:

Substances:

Year:  2013        PMID: 24035596      PMCID: PMC3818408          DOI: 10.1016/j.jneuroim.2013.08.010

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  19 in total

1.  A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells.

Authors:  M Ohno; T Hirata; M Enomoto; T Araki; H Ishimaru; T A Takahashi
Journal:  Mol Immunol       Date:  2000-06       Impact factor: 4.407

2.  Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.

Authors:  D Avichezer; P B Silver; C C Chan; B Wiggert; R R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-01       Impact factor: 4.799

Review 3.  Complement-targeted therapeutics.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Nat Biotechnol       Date:  2007-11       Impact factor: 54.908

4.  Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis.

Authors:  Russell W Read; Alexander J Szalai; Susan D Vogt; Gerald McGwin; Scott R Barnum
Journal:  Exp Eye Res       Date:  2005-09-06       Impact factor: 3.467

5.  Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.

Authors:  J H Sohn; H J Kaplan; H J Suk; P S Bora; N S Bora
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

Review 6.  Cytokines in autoimmune uveitis.

Authors:  Reiko Horai; Rachel R Caspi
Journal:  J Interferon Cytokine Res       Date:  2011-07-25       Impact factor: 2.607

Review 7.  The role of complement system in ocular diseases including uveitis and macular degeneration.

Authors:  Purushottam Jha; Puran S Bora; Nalini S Bora
Journal:  Mol Immunol       Date:  2007-09       Impact factor: 4.407

8.  Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis.

Authors:  D A Copland; K Hussain; S Baalasubramanian; T R Hughes; B P Morgan; H Xu; A D Dick; L B Nicholson
Journal:  Clin Exp Immunol       Date:  2009-12-04       Impact factor: 4.330

Review 9.  The dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis.

Authors:  Emma C Kerr; David A Copland; Andrew D Dick; Lindsay B Nicholson
Journal:  Prog Retin Eye Res       Date:  2008-08-03       Impact factor: 21.198

10.  New developments in C5a receptor signaling.

Authors:  J Vidya Sarma; Peter A Ward
Journal:  Cell Health Cytoskelet       Date:  2012-07-31
View more
  4 in total

Review 1.  Doyne lecture 2016: intraocular health and the many faces of inflammation.

Authors:  A D Dick
Journal:  Eye (Lond)       Date:  2016-09-16       Impact factor: 3.775

2.  Complement anaphylatoxin receptors C3aR and C5aR are required in the pathogenesis of experimental autoimmune uveitis.

Authors:  Lingjun Zhang; Brent A Bell; Minzhong Yu; Chi-Chao Chan; Neal S Peachey; John Fung; Xiaoming Zhang; Rachel R Caspi; Feng Lin
Journal:  J Leukoc Biol       Date:  2015-09-22       Impact factor: 4.962

Review 3.  Autoimmune and autoinflammatory mechanisms in uveitis.

Authors:  Richard W Lee; Lindsay B Nicholson; H Nida Sen; Chi-Chao Chan; Lai Wei; Robert B Nussenblatt; Andrew D Dick
Journal:  Semin Immunopathol       Date:  2014-05-24       Impact factor: 9.623

4.  Increased Complement 3a Receptor is Associated with Behcet's disease and Vogt-Koyanagi-Harada disease.

Authors:  Chaokui Wang; Shuang Cao; Dike Zhang; Hong Li; Aize Kijlstra; Peizeng Yang
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.